Reported Reactions

Devices › Set, administration, intravascular

Device brand name · Insulin infusion set

Accu-Chek Rapid D Infusion Set: medical device reports filed with FDA

281 reports name it, 2008–2011. Manufacturer given most often on reports: Disetronic Medical Systems. Product code FPA.

281
device reports naming the brand
0% of all MAUDE reports · about 15 a year
0
reports, 12 months to August 2026
0 in the 12 months before
25.6%
classified as malfunction
79.3% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 281 reports that name the brand "Accu-Chek Rapid D Infusion Set" (insulin infusion set), received between February 2008 and July 2011; the manufacturer given most often on reports is Disetronic Medical Systems. Spellings of one product vary from report to report.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (74%) and malfunction (25.6%); across all set, administration, intravascular reports (product code FPA) death is recorded in 0.2% and malfunction in 79.3%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are occlusion within device (30.6%), device displays incorrect message (28.8%) and replace (25.3%). The patient problems coded most often are hyperglycemia, blood glucose, high and treatment with medication(s). FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Accu-Chek Rapid D Infusion Set was received in the five years to August 2026; the latest was received in July 2011.

By year received

0621232008: 8120082009: 12320092010: 6020102011: 172011

Event type and report source

Event type, as classified on the report

Death0%0
Injury74%208
Malfunction25.6%72
Other0%0
Not given0.4%1

Who filed the report

Manufacturer report100%281
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 349,387 reports carrying product code FPA. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Occlusion within devicethe device blocked8630.6%0.6%
Device displays incorrect message8128.8%0.8%
Replace7125.3%0.8%
Fluid/blood leak4616.4%13.5%
Bent196.8%0.4%
Improper or incorrect procedure or method165.7%0.4%
Disconnection124.3%1.8%
Failure to prime124.3%0.5%
Partial blockage103.6%1.6%
Breakthe device broke93.2%2.1%
Insufficient device problem information93.2%0.3%
Kinkedthe tube or line kinked93.2%0.2%
Alarm, audible82.8%0.1%
Inadequate or insufficient training82.8%0%
Air leak72.5%0.4%
Failure to deliverthe device did not deliver the dose or item72.5%0.3%
Detachment of device component62.1%0.6%
Failure to adhere or bond62.1%0.4%
High test results62.1%0.1%
Loose62.1%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Hyperglycemiahigh blood sugar11039.1%
Blood glucose, high9935.2%
Treatment with medication(s)7125.3%
Elevated ketones/ diabetic ketoacidosis155.3%
Painpain, site not specified113.9%
Polydipsia113.9%
Nauseafeeling sick103.6%
Therapy/non-surgical treatment, additional93.2%
Fatiguetiredness82.8%
Hypoglycemialow blood sugar82.8%
Hospitalization required72.5%
Malaisegeneral feeling of being unwell72.5%
Vomitingbeing sick72.5%
Urinary frequency / polyuria62.1%
Erythemaskin redness41.4%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureAccu-Chek Rapid D Infusion SetProduct code FPAAll MAUDE reports
Reports281349,38726,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports029
Classified as injury74%20%36.2%
Classified as malfunction25.6%79.3%62.3%
Filed by the manufacturer100%96.3%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code FPA

BrandReportsLatest 12 monthsClassified as death
Inset Guard47,27647,2220.1%
Inset26,40525,6560%
Quick Set23,35123,0280.4%
Autosoft Xc20,328490%
Autosoft 9012,143150%
Access14,16000%
Other Accessories10,42910,4251.7%
Alaris Pump Module Administration Set8,49200.2%
Contact Detach6,4736,1570.1%
Inset 303,5283,4610%
Cadd10,81190.1%
Minimed Quick-Set3,10160%
Cleo 90 Infusion Set3,006230%
Trusteel2,886140%
Autosoft 302,37410%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Accu-Chek Rapid D Infusion Set reports

How many FDA reports name Accu-Chek Rapid D Infusion Set?

281 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

injury (74%) and malfunction (25.6%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

occlusion within device (30.6%), device displays incorrect message (28.8%), replace (25.3%), fluid/blood leak (16.4%) and bent (6.8%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Accu-Chek Rapid D Infusion Set was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.